נגישות
menu      
חיפוש מתקדם
תחביר
חפש...
הספר "אוצר וולקני"
אודות
תנאי שימוש
ניהול
קהילה:
אסיף מאגר המחקר החקלאי
פותח על ידי קלירמאש פתרונות בע"מ -
The effect of barbiturates on the degradation of enkephalin by brain enzymes
Year:
1981
Source of publication :
Life Sciences
Authors :
אלטשטיין, מרים
;
.
Volume :
28
Co-Authors:
Altstein, M., Department of Neurobiology The Weizmann Institute of Science Rehovot, Israel
Mittman, S., Department of Neurobiology The Weizmann Institute of Science Rehovot, Israel
Vogel, Z., Department of Neurobiology The Weizmann Institute of Science Rehovot, Israel
Facilitators :
From page:
185
To page:
191
(
Total pages:
7
)
Abstract:
Several barbiturates inhibit the degradation of enkephalin by the enzyme enkephalinase, a membrane-associated endopeptidase of rat striatum. The barbiturates vary largely in their inhibitory potential toward this enzymatic activity. Secobarbital, pentobarbital, phenobarbital and barbital inhibit the hydrolysis of Leu-enkephalin with IC50 of 8 × 10-6M, 1.8 × 10-5M, 7 × 10-5M and 4 × 10-4M, respectively. The N-1 methyl substituted barbiturates, methohexital and hexobarbital, as well as barbituric acid have very low or no inhibitory activity. The inhibition of Leu-enkephalin degradation by secobarbital exhibits mixed noncompetitive-competitive kinetics with KI S of 2 × 10-5M and KI I of 6 × 10-5M. Solubilization of enkephalinase from the membranes with Triton X-100 does not effect the inhibition by the barbiturates. The barbiturates do not inhibit two other brain enzymes shown to degrade enkephalin, i.e. the enkephalin-degrading aminopeptidase and enkephalinase B. In addition, the hydrolysis of enkephalin by carboxypeptidase A or by thermolysin is not affected by the barbiturates. © 1981.
Note:
Related Files :
Animal
animal experiment
Barbiturates
biotransformation
brain
hexobarbital
Kinetics
Male
עוד תגיות
תוכן קשור
More details
DOI :
10.1016/0024-3205(81)90551-8
Article number:
Affiliations:
Database:
סקופוס
Publication Type:
מאמר
;
.
Language:
אנגלית
Editors' remarks:
ID:
19748
Last updated date:
02/03/2022 17:27
Creation date:
16/04/2018 23:31
Scientific Publication
The effect of barbiturates on the degradation of enkephalin by brain enzymes
28
Altstein, M., Department of Neurobiology The Weizmann Institute of Science Rehovot, Israel
Mittman, S., Department of Neurobiology The Weizmann Institute of Science Rehovot, Israel
Vogel, Z., Department of Neurobiology The Weizmann Institute of Science Rehovot, Israel
The effect of barbiturates on the degradation of enkephalin by brain enzymes
Several barbiturates inhibit the degradation of enkephalin by the enzyme enkephalinase, a membrane-associated endopeptidase of rat striatum. The barbiturates vary largely in their inhibitory potential toward this enzymatic activity. Secobarbital, pentobarbital, phenobarbital and barbital inhibit the hydrolysis of Leu-enkephalin with IC50 of 8 × 10-6M, 1.8 × 10-5M, 7 × 10-5M and 4 × 10-4M, respectively. The N-1 methyl substituted barbiturates, methohexital and hexobarbital, as well as barbituric acid have very low or no inhibitory activity. The inhibition of Leu-enkephalin degradation by secobarbital exhibits mixed noncompetitive-competitive kinetics with KI S of 2 × 10-5M and KI I of 6 × 10-5M. Solubilization of enkephalinase from the membranes with Triton X-100 does not effect the inhibition by the barbiturates. The barbiturates do not inhibit two other brain enzymes shown to degrade enkephalin, i.e. the enkephalin-degrading aminopeptidase and enkephalinase B. In addition, the hydrolysis of enkephalin by carboxypeptidase A or by thermolysin is not affected by the barbiturates. © 1981.
Scientific Publication
You may also be interested in